company

ALDEN CANCER THERAPY AS

5006 BERGEN

Return on Equity
−102,93 %
Current Ratio
26,54
Debt-to-Equity Ratio
1,82
Key figures (NOK)2022
Revenue0
Net Income−984 000
Total Assets2 757 000
Total Equity956 000
Income (NOK)2022
Revenue0
Expenditure987 000
Operating Profit−987 000
Financial Income4 000
Financial Costs1 000
Financial Balance3 000
Earnings Before Tax−984 000
Tax0
Net Income−984 000
Balance (NOK)2022
Total Fixed Assets1 191 000
Total Current Assets1 566 000
Total Assets2 757 000
Total Retained Equity635 000
Total Equity956 000
Total Long-Term Debt1 741 000
Total Current Debt59 000
Total Equity and Debt2 757 000
Cash flow (NOK)2022
Sales Income0
Other Income0
Revenue0
Cost of Goods Sold0
Salary Costs171 000
Depreciation447 000
Impairment0
Expenditure987 000
Operating Profit−987 000
Financial Income4 000
Financial Costs1 000
Financial Balance3 000
Dividends0
Net Income−984 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets198 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures993 000
Total Tangible Assets993 000
Total Fiancial Fixed Assets0
Total Fixed Assets1 191 000
Stock0
Total Investments0
Cash, Bank1 186 000
Total Current Assets1 566 000
Total Assets2 757 000
Total Equity956 000
Short-Term Group Debt0
Total Long-Term Debt1 741 000
Creditors41 000
Unpaid Taxes0
Dividends0
Other Current Debt19 000
Total Current Debt59 000
Total Equity and Debt2 757 000
Financial indicators2022
Return on Equity−102,93 %
Debt-to-Equity Ratio1,82
Operating Profit Margin-
Current Ratio26,54
Quick Ratio26,54
Equity Ratio0,35
Gross Profit Margin-
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English